Neonatal outcomes after in-utero exposure to magnesium sulphate: a retrospective analysis

被引:0
|
作者
Mota, Ricardo Barreto [1 ]
Rey Y Formoso, Vicente [1 ]
Soares, Paulo
Guimarae, Hercilia [2 ,3 ]
机构
[1] Ctr Hosp & Univ Sao Joao, Paediat Dept, Porto, Portugal
[2] Ctr Hosp & Univ Sao Joao, Neonatal Intens Care Unit, Porto, Portugal
[3] Univ Porto, Fac Med, Porto, Portugal
关键词
Magnesium sulphate; cerebral palsy; necrotizing enterocolitis; preterm birth; persistent ductus arteriosus; MORTALITY;
D O I
10.7363/120120
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Magnesium sulphate (MgSO4) is routinely administered to pregnant women as a tocolytic and as a neuroprotective agent against cerebral palsy and motor impairment in preterm neonates. However, concerns have recently been arising regarding its effects in the neonate, including cardiovascular, intestinal, and neurological adverse effects. Our goal is to analyse prenatal MgSO4 administration and neonatal outcomes. Methods: We conducted a retrospective study that included all neonates born under 32 weeks of gestational age admitted to our Neonatal Intensive Care Unit between January 2016 and December 2019. Patients with life-threatening congenital malformations were excluded. Gestational, perinatal and outcome data were collected and statistically analysed. Results: One hundred and eighteen infants were included, of which 61 (51.7%) had been exposed to MgSO4 in utero. Mothers treated with MgSO4 were more likely also to have received corticosteroids for lung maturation and/or perinatal antibiotics. All but 5 (95.8%) infants needed post-natal resuscitation manoeuvres. Neonates that were prenatally exposed to MgSO4 were less likely to require such manoeuvres (p = 0.039), and immediate oxygen therapy (p = 0.015) was less frequently required. The median neonatal serum magnesium was higher in those exposed to MgSO4 (2.51 mEq/L) than in non-exposed (1.87 mEq/L) (p < 0.001). Neonatal serum magnesium values had a positive correlation with maternal prenatal values, with a Spearman's value of 0.78 (p < 0.001). Neonates prenatally exposed to MgSO4 were less likely to require surfactant treatment or aminergic support as well as less likely to have a persistent ductus arteriosus. No other statistically significant differences were found when comparing both groups for other outcomes. Conclusion: Prenatal exposure to MgSO4 is apparently safe for preterm infants. However, the conduction of a larger, prospective study must confirm these data.
引用
收藏
页数:8
相关论文
共 50 条
  • [3] Birth outcomes after in-utero exposure to oral hypoglycaemic drugs
    Chaabane, A
    El Aidli, S
    Kastalli, S
    Ayadi, L
    Daghfous, R
    Lakhal, M
    Loueslati, MH
    Belkahia, C
    DRUG SAFETY, 2005, 28 (10) : 955 - 955
  • [4] Case report: Neonatal delayed peristalsis after in-utero exposure to clozapine
    Moreno-Bruna, M. -D.
    de Montgolfier, I.
    Chabaud, M.
    Dommergues, M.
    ARCHIVES DE PEDIATRIE, 2012, 19 (09): : 913 - 916
  • [5] NEONATAL COMPLICATIONS ASSOCIATED WITH IN-UTERO COCAINE EXPOSURE
    BADA, HS
    KORONES, SB
    ARHEART, KL
    PEDIATRIC RESEARCH, 1994, 35 (04) : A263 - A263
  • [6] IN-UTERO COCAINE EXPOSURE AND INCIDENCE OF NEONATAL COMPLICATIONS
    WAGNER, L
    ARHEART, K
    BADA, H
    KORONES, S
    CLINICAL RESEARCH, 1993, 41 (04): : A770 - A770
  • [7] In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review
    Fitton, Catherine A.
    Steiner, Markus F. C.
    Aucott, Lorna
    Pell, Jill P.
    Mackay, Daniel F.
    Fleming, Michael
    Mclay, James S.
    JOURNAL OF HYPERTENSION, 2017, 35 (11) : 2123 - 2137
  • [8] Adverse fetal and neonatal outcomes following in-utero exposure to oxcarbazepine: A systematic review and meta-analysis
    Athar, Farwa
    Ehsan, Muhammad
    Farooq, Minaam
    Lo, Kevin B.
    Cheema, Huzaifa A.
    Ahmad, Shahzaib
    Naveed, Aiman
    Umer, Mohammad
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (08) : 3600 - 3609